Skip to content
Disclosery

ENAVATE SCIENCES GP, LLC: ZBIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ENAVATE SCIENCES GP, LLC on ZBIO, newest first. How the timeline and the estimate are built.

ENAVATE SCIENCES GP, LLC held 3,919,159 ZBIO shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 3,919,159 shares
    Change vs previous 13F 0 shares

    28.8% of the 13F portfolio, value $99,468,255.

    13F-HR 0001953107-26-000012 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 3,919,159 shares
    Change vs previous 13F 0 shares

    21.8% of the 13F portfolio, value $76,619,558.

    13F-HR 0001953107-26-000008 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 3,919,159 shares
    Change vs previous 13F +157,800 shares

    28.08% of the 13F portfolio, value $142,304,663.

    13F-HR 0001953107-26-000003 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,761,359 shares
    Change vs previous 13F 0 shares

    25.49% of the 13F portfolio, value $83,502,170.

    13F-HR 0001953107-25-000014 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 3,761,359 shares
    Change vs previous 13F 0 shares

    20.65% of the 13F portfolio, value $36,447,569.

    13F-HR 0001415889-25-021852 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 3,761,359 shares
    Change vs previous 13F 0 shares

    22.39% of the 13F portfolio, value $29,714,736.

    13F-HR 0001415889-25-013132 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 3,761,359 shares
    Change vs previous 13F not available

    22.12% of the 13F portfolio, value $30,805,530.

    13F-HR 0001104659-25-014094 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).